News

Preetika Rana is an award-winning reporter for The Wall Street Journal in San Francisco with experience reporting from six ...
Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...
Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...
Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.
Biomedical Research leads at USD 1.5 billion, supporting genetic discovery and translational research.
De-extinction, once a concept of science fiction, is becoming a reality through advancements in gene editing technologies ...
Duke University will award honorary degrees to Dr. Rebecca Buckley ’54, David Robinson II ’64 and Dr. Feng Zhang during its ...
The Asia Pacific region is poised for a significant surge in the CRISPR gene editing market, projected to expand by 28.6% annually over the period of 2022-2031. With a total addressable market cap ...
The CRISPR gene editing technology has revolutionized the field of molecular biology, offering unprecedented precision and efficiency in genetic manipulation. With its vast potential in various ...